(Q42999474)

English

Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin

scientific article published in April 2006

Statements

Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin (English)
Michael von Wagner
Samer Nasser
Christoph Sarrazin
Tilman Gerlach
Peter Buggisch
Jens Rasenack
Gerd R Pape
Wolfgang E Schmidt
Birgit Kallinowski
Hartwig Klinker
Ulrich Spengler
Peter Martus
Ulrich Alshuth
1 April 2006
1086-1097

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit